Production (Stage)
Nu-Med Plus, Inc.
NUMD
$0.052
$0.0024.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -83.18% | 15.23% | -30.74% | -23.70% | 764.06% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -83.18% | 15.23% | -30.74% | -23.70% | 764.06% |
| Operating Income | 83.18% | -15.23% | 30.74% | 23.70% | -764.06% |
| Income Before Tax | 81.27% | -14.02% | 28.81% | 22.70% | -232.86% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 81.27% | -14.02% | 28.81% | 22.70% | -232.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 81.27% | -14.02% | 28.81% | 22.70% | -232.86% |
| EBIT | 83.18% | -15.23% | 30.74% | 23.70% | -764.06% |
| EBITDA | -- | -- | -- | -- | -756.25% |
| EPS Basic | 85.71% | 0.00% | 33.33% | 0.00% | -240.00% |
| Normalized Basic EPS | 75.00% | 0.00% | 50.00% | 0.00% | -300.00% |
| EPS Diluted | 85.71% | 0.00% | 33.33% | 0.00% | -240.00% |
| Normalized Diluted EPS | 75.00% | 0.00% | 50.00% | 0.00% | -300.00% |
| Average Basic Shares Outstanding | 9.07% | 0.00% | 0.00% | 2.70% | 1.58% |
| Average Diluted Shares Outstanding | 9.07% | 0.00% | 0.00% | 2.70% | 1.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |